Ikonisys (ALIKO.PA) Stock Price

Ikonisys Price

Euronext·CLOSED
1.43
​
Market closed

Over the last 6 years Ikonisys grew revenue by 65.1% annually, reaching 1.39 M EUR. For Ikonisys, the net margin of -302.8% is down versus -156.5% a few years ago. The consensus 12-month price target for Ikonisys is 2.86 EUR, about 99.7% above where the stock trades today. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.

Ikonisys stock price

Access this data via the Eulerpool API

Ikonisys business model & stock analysis

Ikonisys SA specializes in the design, manufacture, and distribution of cellular diagnosis applications for cancer, genetic diseases, and fertility problems. The company is headquartered in Paris, Ile-De-France and currently employs 11 full-time employees. The company went IPO on 2021-07-19. The firm offers cell diagnostic products in the fields of cancer diagnosis, detection of genetic disorders, and fertility testing. The company utilizes advanced molecular and immunological markers, Ikoniscope robotic components, software engine, image acquisition, digital microscope and cell detection to design and deliver accurate and reliable detection of rare cells. The company includes clinical diagnostic applications for the diagnosis of different types of cancer, including bladder (oncoFISH bladder), breast (oncoFISH her2), cervical (oncoFISH cervical), prostate (oncoFISH PTEN), lung (oncoFISH ALK) and a variety of hematological cancers utilizing the Explorer applications.

Frequently asked questions about Ikonisys

Analysts currently set an average price target of 2.86 EUR for the Ikonisys stock (median: 2.86 EUR), implying +99.7 % versus the latest price. The consensus is based on 9 analyst ratings.

9 analysts currently rate the Ikonisys stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Ikonisys to generate revenue of 2.00 M EUR and earnings per share of 0.03 EUR.

The Ikonisys share (ALIKO.PA) is listed on 3 stock exchanges, including: Frankfurt (9W8.F), Paris (ALIKO.PA).

The expected revenue of Ikonisys is 2.00 M EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Ikonisys is 475,200.00 EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Ikonisys is currently 47.62. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Ikonisys stock.

The price-to-sales ratio (P/S) of Ikonisys is currently 11.32. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Ikonisys stock.

The Eulerpool Quality Score for Ikonisys is 2/10.

The ISIN of Ikonisys is FR00140048X2. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Ikonisys is A3CVR6. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Ikonisys is ALIKO.PA. The ticker symbol is used to trade Ikonisys shares on the stock exchange.

Fair ValueTerminal
1.24 EUR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
126,184.64 EUR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Country
Currency
EUR
Initial public offering
Jul 19, 2021
ISIN
FR00140048X2
Market capitalization
22.65 M EURMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
47.67
P/Ee 2027
-57.15
P/Ee 2028
—
P/Ee 2029
—
P/Ee 2030
—
P/Se
11.32
EV/EBIT
—
P/B Ratio
1.18
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-18.78 %
Last updated Oct 9, 2026, 10:36 AM

Ikonisys Peer Group

Ikonisys Ticker

EURONEXT · ALIKO.PAFRANKFURT · 9W8.FPARIS · ALIKO.PA

Ikonisys FIGI

ALIKO:FP · BBG011NZ6PM7ALIKOEUR:XH · BBG011RKL6M1ALIKOEUR:XF · BBG011RKL6P8ALIKOEUR:XE · BBG011RKL6R6ALIKOEUR:XL · BBG011RKL6T4ALIKOEUR:XG · BBG011RKL6V1ALIKOEUR:XO · BBG011RKL6W0ALIKOEUR:XA · BBG011RKL703ALIKOEUR:XT · BBG011RKL721ALIKOEUR:XW · BBG011RKL730ALIKOEUR:XU · BBG011RKL749ALIKOEUR:XV · BBG011RKL767

All fundamentals and in-depth analysis of Ikonisys

Our stock analysis for Ikonisys stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ikonisys. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.